Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.
about
The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: disease mongering or call to action?Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
P2860
Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 January 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis.
@en
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis.
@nl
type
label
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis.
@en
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis.
@nl
prefLabel
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis.
@en
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis.
@nl
P2093
P2860
P1476
Screening for Nonalcoholic Ste ...... A Cost-Effectiveness Analysis
@en
P2093
Angela C Tramontano
Matthew J Klebanoff
Raymond T Chung
P2860
P2888
P304
P356
10.1007/S10620-016-4044-2
P577
2016-01-29T00:00:00Z